BIO-key International, Inc.

Introduction

This page provides a comprehensive analysis of the known insider trading history of James David Sullivan. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate James David Sullivan has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:BKYI / BIO-key International, Inc. Chief Legal Officer 94,851
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by James David Sullivan. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases BKYI / BIO-key International, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in BKYI / BIO-key International, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2025-08-22 BKYI Sullivan James David 10,000 0.7700 10,000 0.7700 7,700 0 0.7800 100 1.30
2023-11-30 BKYI Sullivan James David 20,000 0.1650 1,111 2.9700 3,300
2023-11-27 BKYI Sullivan James David 9,803 0.1640 545 2.9520 1,608
2023-11-27 BKYI Sullivan James David 100 0.1800 6 3.2400 18
2023-11-27 BKYI Sullivan James David 100 0.1799 6 3.2382 18
2023-11-24 BKYI Sullivan James David 10,000 0.1600 556 2.8800 1,600
2023-11-24 BKYI Sullivan James David 17,609 0.1650 978 2.9700 2,905
2023-11-24 BKYI Sullivan James David 959 0.1730 53 3.1140 166
2023-11-24 BKYI Sullivan James David 1,100 0.1731 61 3.1158 190
2023-10-30 BKYI Sullivan James David 228,000 0.1750 12,667 3.1500 39,900
2023-10-30 BKYI Sullivan James David 57,100 0.1750 3,172 3.1500 9,992
2023-09-15 BKYI Sullivan James David 96 0.5300 5 9.5400 51
2023-09-15 BKYI Sullivan James David 4,904 0.5500 272 9.9000 2,697
2023-09-11 BKYI Sullivan James David 1,200 0.5200 67 9.3600 624
2023-09-11 BKYI Sullivan James David 3,800 0.5300 211 9.5400 2,014
2023-09-11 BKYI Sullivan James David 4,000 0.5280 222 9.5040 2,112
2023-08-31 BKYI Sullivan James David 5,000 0.5500 278 9.9000 2,750
2022-09-14 BKYI Sullivan James David 2,650 1.6200 147 29.1600 4,293
2022-09-12 BKYI Sullivan James David 968 1.5700 54 28.2600 1,520
2022-09-08 BKYI Sullivan James David 2,377 1.5200 132 27.3600 3,613
2022-08-24 BKYI Sullivan James David 18 1.7000 1 30.6000 31
2022-08-24 BKYI Sullivan James David 2,406 1.7100 134 30.7800 4,114
2022-08-24 BKYI Sullivan James David 2,581 1.7200 143 30.9600 4,439
2022-06-14 BKYI Sullivan James David 3,000 1.6899 167 30.4182 5,070
2022-06-14 BKYI Sullivan James David 416 1.6700 23 30.0600 695
2022-06-13 BKYI Sullivan James David 84 1.7000 5 30.6000 143
2021-11-24 BKYI Sullivan James David 1,500 2.5600 83 46.0800 3,840
2021-11-24 BKYI Sullivan James David 500 2.5700 28 46.2600 1,285
2021-08-19 BKYI Sullivan James David 2,000 3.1000 111 55.8000 6,200
2021-08-19 BKYI Sullivan James David 3,000 2.9200 167 52.5600 8,760
2021-05-20 BKYI Sullivan James David 5,000 3.3200 278 59.7600 16,600
2021-05-20 BKYI Sullivan James David 897 3.3360 50 60.0480 2,992
2021-05-20 BKYI Sullivan James David 4,103 3.3700 228 60.6600 13,827
2020-11-24 BKYI Sullivan James David 5,000 3.2100 278 57.7800 16,050
2020-11-23 BKYI Sullivan James David 5,000 3.4000 278 61.2000 17,000

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

BKYI / BIO-key International, Inc. Insider Trades
Insider Sales BKYI / BIO-key International, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in BKYI / BIO-key International, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

BKYI / BIO-key International, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by James David Sullivan as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-09-03 2025-09-02 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
A - Award 40,000 94,851 72.92
2025-08-26 2025-08-22 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 10,000 54,851 22.30 0.77 7,700 42,235
2025-07-02 2025-06-30 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
A - Award 139 44,851 0.31 0.70 97 31,396
2025-01-03 2024-12-31 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
A - Award 139 44,712 0.31 1.40 195 62,597
2024-08-02 2024-07-31 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
A - Award 22,500 44,573 101.93
2024-07-02 2024-06-28 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
A - Award 139 22,073 0.63 1.39 194 30,770
2024-01-03 2023-12-29 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
A - Award 139 21,934 0.64 2.55 354 55,932
2023-12-04 2023-11-30 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 20,000 388,171 5.43 0.16 3,300 64,048
2023-11-28 2023-11-27 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 100 368,171 0.03 0.18 18 66,234
2023-11-28 2023-11-27 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 100 368,071 0.03 0.18 18 66,253
2023-11-28 2023-11-27 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 9,803 367,971 2.74 0.16 1,608 60,347
2023-11-28 2023-11-24 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 1,100 358,168 0.31 0.17 190 61,999
2023-11-28 2023-11-24 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 959 357,068 0.27 0.17 166 61,773
2023-11-28 2023-11-24 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 17,609 356,109 5.20 0.16 2,905 58,758
2023-11-28 2023-11-24 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 10,000 338,500 3.04 0.16 1,600 54,160
2023-11-01 2023-10-30 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 57,100 415,600 15.93 0.18 9,992 72,730
2023-11-01 2023-10-30 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 228,000 358,500 174.71 0.18 39,900 62,738
2023-09-18 2023-09-15 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 4,904 130,500 3.90 0.55 2,697 71,775
2023-09-18 2023-09-15 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 96 125,596 0.08 0.53 51 66,566
2023-09-12 2023-09-11 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 4,000 125,500 3.29 0.53 2,112 66,264
2023-09-12 2023-09-11 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 3,800 121,500 3.23 0.53 2,014 64,395
2023-09-12 2023-09-11 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 1,200 117,700 1.03 0.52 624 61,204
2023-09-05 2023-08-31 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 5,000 116,500 4.48 0.55 2,750 64,075
2023-08-31 2023-08-29 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
A - Award 30,000 111,500 36.81
2023-07-05 2023-06-30 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
A - Award 2,500 81,500 3.16 0.50 1,243 40,530
2023-01-09 2022-12-30 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
A - Award 2,500 79,000 3.27 0.50 1,243 39,287
2022-09-14 2022-09-14 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 2,650 76,500 3.59 1.62 4,293 123,930
2022-09-14 2022-09-12 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 968 73,850 1.33 1.57 1,520 115,944
2022-09-12 2022-09-08 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 2,377 72,882 3.37 1.52 3,613 110,781
2022-08-25 2022-08-24 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 2,581 70,505 3.80 1.72 4,439 121,269
2022-08-25 2022-08-24 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 2,406 67,924 3.67 1.71 4,114 116,150
2022-08-25 2022-08-24 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 18 65,518 0.03 1.70 31 111,381
2022-07-05 2022-06-30 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
A - Award 2,500 65,500 3.97 1.50 3,761 98,545
2022-06-28 2022-06-14 4/A BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 416 63,000 0.66 1.67 695 105,210
2022-06-28 2022-06-14 4/A BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 3,000 62,584 5.03 1.69 5,070 105,761
2022-06-28 2022-06-13 4/A BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 84 59,584 0.14 1.70 143 101,293
2022-06-15 2022-06-14 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
A - Award 416 63,000 0.66 1.67 695 105,210
2022-06-15 2022-06-14 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
A - Award 3,000 62,584 5.03 1.69 5,070 105,761
2022-06-15 2022-06-13 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
A - Award 84 59,584 0.14 1.70 143 101,293
2022-03-15 2022-03-11 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
A - Award 30,000 59,500 101.69
2022-01-04 2021-12-31 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
A - Award 2,500 29,500 9.26 1.88 4,700 55,460
2021-11-29 2021-11-24 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 500 27,000 1.89 2.57 1,285 69,390
2021-11-29 2021-11-24 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 1,500 26,500 6.00 2.56 3,840 67,840
2021-08-20 2021-08-19 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 3,000 25,000 13.64 2.92 8,760 73,000
2021-08-20 2021-08-19 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 2,000 22,000 10.00 3.10 6,200 68,200
2021-05-21 2021-05-20 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 4,103 20,000 25.81 3.37 13,827 67,400
2021-05-21 2021-05-20 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 897 15,897 5.98 3.34 2,992 53,032
2021-05-21 2021-05-20 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 5,000 15,000 50.00 3.32 16,600 49,800
2020-12-02 2020-11-24 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 5,000 14,125 54.79 3.21 16,050 45,341
2020-12-02 2020-11-23 4 BKYI BIO KEY INTERNATIONAL INC
Common Stock
P - Purchase 5,000 9,125 121.21 3.40 17,000 31,025
2020-12-01 3 BKYI BIO KEY INTERNATIONAL INC
Common Shares, par value $0.0001
4,125
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)